Kohjin Bio Co., Ltd. (TYO:177A)
580.00
-35.00 (-5.69%)
Nov 18, 2026, 11:05 AM JST
Kohjin Bio Market Cap
Kohjin Bio has a market cap or net worth of 2.96 billion as of November 17, 2026. It is the 36,359th most valuable company in the world and the 3,347th biggest in Japan. Its market cap has decreased by 63.13% in one year.
Market Cap
2.96B
Enterprise Value
2.26B
Revenue
4.38B
Global Rank
Country Rank
#3,347 Japan
PE Ratio
n/a
ChartMarket Cap Chart
Since April 25, 2024, Kohjin Bio's market cap has decreased from 11.89B to 2.96B, a decrease of -75.06%. That is a compound annual growth rate of -41.78%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 18, 2026 | 2.96B | -61.05% |
| Dec 30, 2025 | 7.61B | -11.16% |
| Dec 30, 2024 | 8.57B | -27.92% |
| Apr 25, 2024 | 11.89B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Kringle Pharma | 4.55B |
| MEDINET | 4.27B |
| SUSMED,Inc. | 4.25B |
| Noile-Immune Biotech | 3.52B |
| PRISM BioLab Co.,LTD | 3.36B |
| Chordia Therapeutics | 3.33B |
| Ribomic | 3.18B |
| Transgenic Group | 3.15B |